Home / Inspections / 1090664

FDA Inspection 1090664 — Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. — FEI 1971534

The FDA completed an inspection of Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on May 1, 2019 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Topeka, KS (United States)

Facility

Other inspections at this facility

  • 1313468 (NAI Thu Mar 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996509 (NAI Thu Dec 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903947 (NAI Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836157 (VAI Mon Jun 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 767479 (VAI Mon Jan 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources